Press Releases September 2, 2026 04:15 PM

Flyte Secures International Approval to Launch Private Aviation Service Across The Bahamas and Caribbean

Flyte expands private aviation services internationally to The Bahamas and Caribbean, broadening its market reach beyond the U.S.

By Jordan Park
Share
Twitter Reddit Facebook LinkedIn
VTAK

Flyte, a subsidiary of Catheter Precision, Inc. (NYSE American: VTAK), has secured international regulatory approvals to expand its private charter flight operations from Florida to The Bahamas and Caribbean. This expansion unlocks new regional markets, allowing Flyte to connect major South Florida population centers with high-demand leisure destinations using its fleet of Cirrus Vision Jets. The move aims to boost aircraft utilization, demand, and customer growth by marketing through direct channels and partnerships.

Flyte Secures International Approval to Launch Private Aviation Service Across The Bahamas and Caribbean
VTAK
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Flyte received approvals to operate flights from Florida to The Bahamas and Caribbean, significantly expanding its addressable market internationally.
  • The company plans immediate commercialization targeting leisure, second-home, and resort travelers, leveraging Florida as a strategic hub.
  • Utilization of Cirrus Vision Jets facilitates efficient service on short regional routes underserved by larger private jets, supporting Flyte’s strategy to build regional operating density.

Landmark international milestone unlocks significant new markets and broadens Flyte’s addressable aviation footprint beyond the United States

New capabilities connect Flyte’s growing Florida network with high-demand leisure and resort destinations throughout The Bahamas and Caribbean

Flyte to begin immediate commercialization through direct-to-consumer marketing and strategic partnerships, targeting increased demand, aircraft utilization and customer growth

FORT MILL, S.C., Sept. 02, 2026 (GLOBE NEWSWIRE) -- Flyte, a subsidiary of Catheter Precision, Inc. (NYSE American: VTAK), today announced that it has received the necessary approvals to expand flight operations from the United States into The Bahamas and Caribbean, marking an important expansion of Flyte’s addressable market and regional operating footprint.

The approval enables Flyte to offer private charter service connecting its growing Florida presence with destinations throughout The Bahamas and Caribbean, opening an entirely new geographic market for the company.

With Florida serving as one of Flyte’s core growth markets, the expansion creates a natural extension of the company’s existing short-haul private aviation model. Major population centers across South Florida sit within close proximity to some of the most highly traveled leisure destinations in The Bahamas and Caribbean, making them particularly well suited for Flyte’s fleet of Cirrus Vision Jets.

“This is a major step forward for Flyte and our expansion throughout the Southeast,” said Marc Sellouk, Founder & CEO. “Florida has always been an important piece of our growth strategy, but the opportunity becomes significantly larger when our network extends beyond the Florida coastline. We can now connect our customers directly to some of the most desirable destinations in The Bahamas and Caribbean while continuing to build the regional aviation network we believe Flyte is uniquely positioned to serve.”

Flyte expects the new capabilities to create additional demand across leisure, second-home and resort travel while increasing the number of destinations that can be served by aircraft positioned throughout Florida.

Potential routes include service from Miami, Fort Lauderdale, Palm Beach, Naples and other Florida markets to destinations such as Nassau, Bimini, Marsh Harbour, Eleuthera and additional Caribbean destinations within the operating range of Flyte’s fleet.

The Cirrus Vision Jet is particularly well suited for these missions, allowing Flyte to provide customers with an efficient private aviation option for regional routes that can be underserved or economically inefficient for larger traditional private jets.

The expansion also supports Flyte’s broader strategy of building density around regional operating hubs. As Flyte continues to grow its fleet, the company intends to strategically position aircraft in markets where each aircraft can serve both strong domestic demand and surrounding regional destinations.
“The value of our Florida operation changes dramatically as we expand the number of destinations those aircraft can serve,” added Sellouk. “An aircraft based in Florida is no longer limited to connecting cities within the state or Southeast. It can now serve an international leisure market sitting just off the coast. We believe that creates a meaningful opportunity to drive additional demand, increase aircraft utilization and continue expanding the Flyte customer base.”

Flyte plans to begin marketing its expanded Bahamas and Caribbean capabilities immediately through its direct-to-consumer platform, strategic partnerships and existing customer network.

About Flyte
Flyte is a technology-driven private aviation company focused on modernizing regional private travel. Through its growing fleet of Cirrus Vision Jets and direct-to-consumer booking platform, Flyte provides customers with a simple and efficient way to book private flights throughout its expanding network. Flyte is focused on connecting high-demand regional markets while leveraging technology, strategic fleet positioning and a differentiated aircraft platform to make private aviation more accessible and efficient.

For more information, visit flyflyte.com.


Risks

  • Dependence on continued regulatory compliance and approvals in international jurisdictions could limit expansion or cause operational disruptions.
  • Economic or travel demand downturns in leisure and resort sectors could reduce demand for private charter services in the Caribbean region.
  • Competition from other private aviation providers or alternative travel options may impact market share and pricing power.

More from Press Releases

New England Journal of Medicine Publishes Phase 1/2 Clinical Data on Revolution Medicines’ RASONQUE™ (daraxonrasib) in Metastatic Non-Small Cell Lung Cancer Sep 2, 2026 BioRestorative Therapies Announces Reverse Stock Split Sep 2, 2026 Capital Southwest Increases Corporate Credit Facility to $595 million and Extends Maturity to September 2031 Sep 2, 2026 Archimedes Tech SPAC Partners II Co. Announces Filing of Third Amendment to Registration Statement on Form S-4 with the SEC Sep 2, 2026 Sprott Focus Trust, Inc. (Nasdaq-FUND) Declares Third Quarter Common Stock Distribution of $0.1503 Per Share Sep 2, 2026